(Q61906677)

English

Acquired immunodeficiency syndrome-associated lymphomas are efficiently lysed through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by rituximab

scientific article published in December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Acquired immunodeficiency syndrome-associated lymphomas are efficiently lysed through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by rituximab (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Daniela Capello

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Martino Introna

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Rosanna Gramigna

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Valeria Facchinetti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Gianluca Gaidano

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

923-929

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

Epidemiology of AIDS-related tumours in developed and developing countries

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

Engineered antibodies with increased activity to recruit complement

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

Emerging information on the use of rituximab in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

Pathology of AIDS-related lymphomas and other AIDS-defining neoplasms

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

Clinical aspects and management of AIDS-related lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

The supportive role of complement in HIV pathogenesis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03935.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2002.03935.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12472569%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61906677&oldid=2047200826"